This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

California's 2026 APRN Practice Reforms: What AB 583 And AB 876 Mean For NPs, CRNAs, And Healthcare Facilities

AB 583 authorizes nurse practitioners (NPs), effective July 1, 2026, to complete and attest to death and fetal death certificates, determine and record causes of death, amend vital records...

United States Healthcare

DW

Davis Wright Tremaine

Health Headlines: October 2025

While there is widespread belief that Congress will reinstate the Medicare telehealth flexibilities and retroactively reimburse services provided during the shutdown, not all providers are willing or able to take that risk.

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

FDA's recent support and presentations at meetings on Regulatory Submissions with Real-World Evidence: Successes, Challenges...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Senate Passes Revised Version Of The BIOSECURE Act

On October 9, 2025, the U.S. Senate voted in favor of including a revised version of the BIOSECURE Act as an amendment to the National Defense Authorization Act (NDAA).

United States Healthcare

HP

Hyman, Phelps, & McNamara

RWE And AI: Hand In Hand In The Future Of Regulatory Decision Making

United States Healthcare

HP

Hyman, Phelps, & McNamara

Inaugural Class Of Commissioner's National Priority Voucher Recipients Announced

United States Healthcare

HP

Hyman, Phelps, & McNamara

Ready Or Not: HRSA's 340B Rebate Pilot Model Takes Off Despite Questions On Readiness And Authority

United States Healthcare

PL

Polsinelli LLP

Food Venture Financing News – Weekly Issue No. 259

United States Healthcare

DW

Davis Wright Tremaine

FDA Grants Interchangeability Designation To Fresenius Kabi's And Celltrion's Denosumab Biosimilars

United States Healthcare

GP

Goodwin Procter LLP

DOJ's Subpoena Strategy On Transgender Care Faces Judicial And State Pushback

United States Healthcare

M

Mintz

A Look Ahead: Major Industry Trends Our Healthcare Team Is Tracking

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Texas Sues Johnson & Johnson And Kenvue Over Tylenol: Scientific Evidence, Regulatory Shifts, And The Future Of OTC Drug Labeling

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS Divided: Can Consumers Be Trusted With Low-Risk Products?

United States Healthcare

HP

Hyman, Phelps, & McNamara

Jones Walker On Digital Healthcare Growth

United States Healthcare

JW

Jones Walker

See more

Webinars

See More

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Recorded on 21 Jan 2025 | 3:00 PM

2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq

TC

CBA In-House Lawyers

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Healthcare

Shutdown Patience Wearing Thin? (Beltway Buzz, October 31, 2025)

The Beltway Buzz™ is a weekly update summarizing labor and employment news from inside the Beltway and clarifying how what's happening in Washington, D.C., could impact your business.

United States Employment

OD

Ogletree, Deakins, Nash, Smoak & Stewart

California's 2026 APRN Practice Reforms: What AB 583 And AB 876 Mean For NPs, CRNAs, And Healthcare Facilities

AB 583 authorizes nurse practitioners (NPs), effective July 1, 2026, to complete and attest to death and fetal death certificates, determine and record causes of death, amend vital records...

United States Healthcare

DW

Davis Wright Tremaine

Health Headlines: October 2025

While there is widespread belief that Congress will reinstate the Medicare telehealth flexibilities and retroactively reimburse services provided during the shutdown, not all providers are willing or able to take that risk.

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

United States Healthcare

HP

Hyman, Phelps, & McNamara

Ready Or Not: HRSA's 340B Rebate Pilot Model Takes Off Despite Questions On Readiness And Authority

United States Healthcare

PL

Polsinelli LLP

DOJ's Subpoena Strategy On Transgender Care Faces Judicial And State Pushback

United States Healthcare

M

Mintz

A Look Ahead: Major Industry Trends Our Healthcare Team Is Tracking

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Texas Sues Johnson & Johnson And Kenvue Over Tylenol: Scientific Evidence, Regulatory Shifts, And The Future Of OTC Drug Labeling

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

HHS Divided: Can Consumers Be Trusted With Low-Risk Products?

United States Healthcare

HP

Hyman, Phelps, & McNamara

See more

Life Sciences, Biotechnology & Nanotechnology

Senate Passes Revised Version Of The BIOSECURE Act

On October 9, 2025, the U.S. Senate voted in favor of including a revised version of the BIOSECURE Act as an amendment to the National Defense Authorization Act (NDAA).

United States Healthcare

HP

Hyman, Phelps, & McNamara

HHS Divided: Can Consumers Be Trusted With Low-Risk Products?

Since his appointment, he has indicated his desire to allow individuals to try healing themselves as they see fit, regardless of FDA approval, stating, "We want to make sure that information is out there.

United States Healthcare

HP

Hyman, Phelps, & McNamara

New FDA Guidance Could Speed Biosimilar Approvals And Cut Costs

On Oct. 29, 2025, the FDA announced draft guidance on how it will assess biosimilar medicines. The 2025 Draft Guidance is intended to reduce the time and expense necessary...

United States Healthcare

PL

Polsinelli LLP

Key Healthcare And Life Sciences Regulatory Updates And Enforcement Trends In 2025 & Beyond

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Self-Audits In Transactional Due Diligence And Enforcement Contexts – Prepare Your Company

United States Environment

SJ

Steptoe LLP

Teva And Prestige Biopharma Enter Licensing Agreement To Commercialize Their Trastuzumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Virtual And Digital Health Digest – October 2025

United States Healthcare

AP

Arnold & Porter

CRLs Unveiled: Converting FDA Transparency Into A Market Advantage

United States Healthcare

AM

Alvarez & Marsal

Holland & Knight Health Dose: October 28, 2025

United States Healthcare

HK

Holland & Knight

See more

Food and Drugs Law

Health Headlines: October 2025

While there is widespread belief that Congress will reinstate the Medicare telehealth flexibilities and retroactively reimburse services provided during the shutdown, not all providers are willing or able to take that risk.

United States Healthcare

GP

Goodwin Procter LLP

Current Opportunities And Challenges In RWE And Its Future With AI

FDA's recent support and presentations at meetings on Regulatory Submissions with Real-World Evidence: Successes, Challenges...

United States Healthcare

HP

Hyman, Phelps, & McNamara

Senate Passes Revised Version Of The BIOSECURE Act

On October 9, 2025, the U.S. Senate voted in favor of including a revised version of the BIOSECURE Act as an amendment to the National Defense Authorization Act (NDAA).

United States Healthcare

HP

Hyman, Phelps, & McNamara

RWE And AI: Hand In Hand In The Future Of Regulatory Decision Making

United States Healthcare

HP

Hyman, Phelps, & McNamara

Inaugural Class Of Commissioner's National Priority Voucher Recipients Announced

United States Healthcare

HP

Hyman, Phelps, & McNamara

Streamlining The Studies: New FDA Guidance Aims To Speed Up Biosimilar Development

United States IP

AV

Axinn Veltrop & Harkrider

Ready Or Not: HRSA's 340B Rebate Pilot Model Takes Off Despite Questions On Readiness And Authority

United States Healthcare

PL

Polsinelli LLP

Food Venture Financing News – Weekly Issue No. 259

United States Healthcare

DW

Davis Wright Tremaine

FDA Grants Interchangeability Designation To Fresenius Kabi's And Celltrion's Denosumab Biosimilars

United States Healthcare

GP

Goodwin Procter LLP

See more

Latest Videos

See more

Ready To Deal: What Healthcare Providers Need To Know Before Raising Capital Or Selling (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

The Journey To Better Healthcare With Ben Kruger (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Upcoming Events

Complete Response Letters In Transition: Navigating FDA’s Transparency Policy And Manufacturing-Related Actions, And How To Respond

United States Healthcare

AP

Arnold & Porter

Top Take-Aways From CMS’ Final 2026 OPPS, PFS, IPPS Rules

United States Healthcare

FL

Foley & Lardner

Crucial Conversations: Value-Based Care (VBC) Partnerships

United States Healthcare

HK

Holland & Knight

ATA EDGE 2025 Policy Conference

United States Healthcare

FL

Foley & Lardner

MAHP Annual Conference: Federal Health Policy – Where Do We Go From Here?

United States Healthcare

FH

Foley Hoag LLP

New England MedTech Conference

United States Healthcare

FH

Foley Hoag LLP

11th Annual Nashville Healthcare Fraud Conference

United States Healthcare

BB

Bass, Berry & Sims

GC Healthcare Roundtable Discussion - A Fireside Chat With Dr. Susan Monarez, Former CDC Director

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More